Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.
A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.
PNNL researchers and professional staff led discussions ranging from biothreats and climate change to science careers at the 2020 annual meeting of the American Association for the Advancement of Science, held this year in Seattle.
A new study focusing on the proteins involved in endometrial cancer, commonly known as uterine cancer, offers insights about which patients will need aggressive treatment and which won’t.
PNNL scientists Richard (Dick) Smith and Ljiljana (Lili) Paša-Tolić are recognized by The Analytical Scientist in its 2019 Power List as two of 2019’s top 100 minds in analytical science.
When two powerful earthquakes rocked southern California earlier this month, officials’ attention focused, understandably, on safety. How many people were injured? Were buildings up to code? How good are we at predicting earthquakes?
Patricia Huestis, a collaborator in the Interfacial Dynamics in Radioactive Environments and Materials (IDREAM) Energy Frontier Research Center, has been awarded the DOE Office of Science Graduate Student Research (SCGSR) award.
PNNL scientists today unveiled an updated tool designed to help stakeholders assess the nation's preparedness for biological-based dangers, also known as biothreats.
Fifteen PNNL scientists are part of a team that has identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.
